Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by juniper88on Mar 27, 2024 10:44am
94 Views
Post# 35955359

RE:RE:RE:RE:RE:Voting for AGM

RE:RE:RE:RE:RE:Voting for AGMI have similar thoughts.  

Any thoughts on what might be an acceptable share price for Soleus?  Based on how much they got in for.

Like you I bought quite a few shares when this went down to $1.30 Canadian.  

palinc2000 wrote: Zwick'S has one mission.....Put some lipstick on the Company and get the Company ready for a takeover to minimize Soleus 's loss

I am now 100% positive that he is Soleus nominee and consequently getting compensated by Soleus and maybe with an additional incentive to share in the rise of the SP

Dawn and Paul and Dubuc need to go asap for the Plan to work 


juniper88 wrote:
PWIB123 and Manequin I am on the same page with both of you on this.

One thing I have to wonder about.  Why would someone with Zwick's seemingly considerable talent and experience possibly touch the like of Thera with a ten feet pole, let alone become a board member?

Any thoughts? 
 
PWIB123 wrote: It doesn't even matter to me if they show efficacy or have good results from TH-1902.  They've had too many blunders, too many mistakes, and have proven they are incapable of communicating properly or driving shareholder value.  I'm voting against every one of them except Zwick on the premise that they have yet to demonstrate any sense of proper leadership.  They may have protected themselves, but I'm still going to vote against them.

Trogarzon wrote: Again I will vote my shares against ALL execpt the new guy Zwick.  Also, I will ask everyone I know to vote their shares this year once again.  Unless they have really good efficacity in part 3 of P1 th1902 and it's not designed for that well they will be voted OUT.




PWIB123




<< Previous
Bullboard Posts
Next >>